In order to better define the role of HDL apos in determining plasma HDL concentration, the aim of the present study was: a) to compare the in vivo rate of plasma turnover of HDL apos (i.e., apoA-I, apoC-I, apoC-III and apoE), and b) to investigate to what extent these metabolic parameters are related to plasma HDL levels.
Data were obtained from 16 individuals who had previously participated in stable isotope-infusion studies focussing on the metabolism of apoC-I, apoC-III and/or apoE in TRL (24-26). These subjects had quite different HDL concentrations, with a three-fold range in HDL cholesterol (HDL-C) and a 2-fold range in plasma apoA-I. Since the intravenous infusion of deuterated leucine in a stable isotope study results in labelled leucine being incorporated into all plasma proteins, we were able to retrospectively isolate apoA-I from stored blood samples taken from study subjects and directly measure apoA-I kinetic parameters for these individuals. This provided a unique opportunity to compare plasma mass and kinetic parameters for apoE, apoC-I, apoC-III and apoA-I in HDL.
by guest, on October 30, 2017 www.jlr.org Downloaded from fraction were isolated from 5 ml of plasma by sequential ultracentrifugation in an XL-90 ultracentrifuge, using a 50. 4 Ti rotor (Beckman, 50,000 rpm for 10 h), at densities (d) of 1.006, 1.063 and 1.21 g/ml, respectively. All lipoprotein fractions were recovered by tube-slicing and were adjusted to a volume of 2.5 ml with physiological saline. ApoC-I in HDL was separated from other apolipoproteins by preparative electrophoresis using polyacrylamide-urea (8M) gels (pH 9.1) (29). ApoA-I, apoC-III and apoE were separated by preparative isoelectric focusing (IEF) on 7.5% polyacrylamide-urea (8M) gels (pH gradient 4-7) (30). Coumassie blue staining was used to identify the position of apolipoproteins in gels after electrophoresis. Plasma and lipoprotein fractions were assayed for total (free and esterified) cholesterol and triglyceride with a COBAS MIRA-S automated analyzer (Hoffman-LaRoche) using enzymatic reagents. Plasma apoA-I concentrations were measured by nephelometry on a Behring Nephelometer 100 (Behring) using Behring protocol and reagents. Since > 90% of plasma apoA-I was consistently found in the HDL fraction after ultracentrifugation (1.063 < d < 1.21 g/ml), plasma apoA-I concentrations were taken to represent HDL apoA-I levels. Plasma and HDL apoC-I, apoC-III and apoE concentrations were measured with ELISAs developed in our laboratory (26, 31, 32) . Immunopurified polyclonal goat anti-human antibodies (Biodesign, Kennebunk, ME) were used for both capture and detection. Assays were calibrated with standard plasmas kindly provided by Dr. Petar Alaupovic (Oklahoma Medical Research Foundation, Oklahoma City). Intraassay and interassay CVs were between 2% and 10%. As explained before (24-26), apoC-I, apoC-III and apoE recovered in the d > 1.21 g/ml fraction (1.9 ± 0.4, 0.5 ± 0.1 and 14.6 ± 0.9% of total, resp.) were included in HDL fractions, which were in turn corrected so that total apolipoprotein recovery after ultracentrifugation was 100%.
Determination of isotopic enrichment. Apolipoprotein bands, as well as blank (nonprotein containing) gel slices were excised from polyacrylamide gels. Each slice was by guest, on October 30, 2017 www.jlr.org Downloaded from added to a borosilicate sample vial containing 600 µl of 6N HCL, and an internal standard of 250 ng norleucine (Sigma-Aldrich) dissolved in 50 µl double distilled water.
Gel slices were hydrolyzed at 110 o C for 24 h, cooled to -20 o C for 20 min, and centrifuged at 3,500 rpm for 5 min. Free amino acids in the hydrolysate were separated from precipitated polyacrylamide, purified by cation exchange chromatography using AG 50 W-X8 resin (BioRad), and derivatized by treatment with 200 µl of acetyl chlorideacidified 1-propanol (1:5 V/V) for 1 h at 100 o C, and 50 µl of heptaflurobutyric anhydride (Supelco) for 20 min at 60 o C (27) . Plasma amino acids were also separated by cation exchange chromatography and derivatized to allow for the determination of plasma leucine isotopic enrichment. Enrichment of samples with deuterium-labeled leucine was measured by gas chromatography/mass spectrometry (Hewlett-Packard, 5988 GC-MS) using negative chemical ionization and methane as the moderator gas. Selective ion monitoring at m/z =352 and 349 (ionic species corresponding to derivatized deuteriumlabeled and derivatized non-deuterium-labeled leucine, respectively) was performed, and tracer to tracee ratios were derived from isotopic ratios for each sample. Tracer to tracee ratios were corrected for background leucine in gel slices (and for leucine introduced during the amino acid purification and derivitization procedures) by estimating the amount of leucine in processed blank gel slices in relation to the norleucine internal standard. Background leucine represented 10% or less of total leucine recovered in apolipoprotein samples. (measured 8 times during the course of the infusion experiment) was used as a measure of precursor pool enrichment. VLDL apoB-100 enrichment at plateau is a better estimate of precursor pool enrichment, but since this plateau was not well-defined in some subjects with elevated VLDL apoB-100, plasma leucine was used for all individuals. (Since the plasma leucine plateau is usually 10% to 15% higher than that of VLDL apoB-100, this may have resulted in a 10-15% underestimation of FCRs for all apolipoproteins). Mean (± SE) plasma leucine tracer to tracee ratio was 10.42 ± 0.56% (n = 16). Modeling of tracer to tracee ratio data resulted in the determination of fractional transport rates (FTR) (i.e., the fraction of HDL apo pools being renewed per day 
Results
Characteristics of study subjects. Plasma lipid and apo concentrations of study subjects (n = 16) in the fasted state, on the day of the stable-isotope infusion experiment, are shown in Table I (Table I) .
Incorporation of labeled leucine into HDL apolipoproteins. Incorporation of deuterated leucine into HDL apolipoproteins was measured as a percentage change in tracer to
tracee ratio (%ttr) over the 12-hr infusion period ( Table II . Plasma HDL apoE concentration (in mg/dl) was significantly lower than that of HDL apoC-III, which was in turn significantly lower than that of HDL apoC-I, which was in turn significantly lower than that of HDL apoA-I (P < 0.01). In molar terms, the concentration profile of HDL apolipoproteins remained the same, such that the concentration of HDL apoE < HDL apoC-III < HDL apoC-I < HDL apoA-I. The average ratio of molecules in the HDL fraction was 1:7:14:60 (i.e., apoE:apoC-III:apoC-I:apoA-I .day -1 , apoA-I had the highest rate of transport and HDL apoC-III had the lowest rate of transport, with HDL apoE and apoC-I being intermediate. In molar terms however, all four HDL apolipoproteins had significantly different rates of transport (P < 0.01), and in magnitude were ordered similar to HDL molar concentrations (i.e., apoE < apoC-III < apoC-I < apoA-I). In relative terms, the ratio between average molar transport rates was 1:2:4:12 (i.e., apoE:apoC-III:apoC-I:apoA-I). The average plasma residence time of apoE in HDL was 1.1 day, while the average residence time of HDL apoA-I was 5.1 days. The average plasma residence times of HDL apoC-III and apoC-I were very similar (3.6 and 3.7 days respectively) which were intermediate between HDL apoE and apoA-I. Mean fractional catabolic rates (i.e., the reciprocal of residence time)
were therefore 0.91, 0.28, 0.27, and 0.20 pools/day, for HDL apoE, apoC-III, apoC-I and apoA-I, respectively.
Relationship between HDL apolipoprotein levels and kinetic parameters. Simple linear regression analysis was carried out to determine which HDL parameters were statistically correlated (Table III) . As expected, HDL cholesterol and HDL apoA-I concentrations were significantly correlated (r = 0.52, P < 0.05). A statistically significant correlation was also observed between HDL apoC-III and HDL cholesterol (r = 0.66, P < 0.01) and between HDL-apoC-III and HDL apoA-I (r = 0.72, P < 0.01). The remaining correlation coefficients in Table III and HDL cholesterol levels were significantly correlated with HDL apoA-I residence times (r = 0.56 and r = 0.69), and were not significantly correlated with HDL apoA-I transport rates. This result is shown graphically in Fig. 2 . In contrast, HDL apoE, apoC-III and apoC-I levels were all positively related to their transport rates and not their residence times. Positive relationships between transport rates and HDL apoE, apoC-III and apoC-I levels (r = 0.66, P < 0.01; r = 0.73, P < 0.01 and r = 0.62, P < 0.05, resp.), are shown in Fig. 2 , contrasting to data for apoA-I. Importantly, HDL apoC-III transport rates were postively correlated with both HDL cholesterol and apoA-I levels (r = 0.54 and r = 0.53, P < 0.05, resp.), and HDL apoC-III transport rates were in turn related to HDL apoA-I residence times (r = 0.51, P < 0.05).
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Discussion
The present study has allowed for a direct comparison to be made between the plasma concentration and kinetics of four HDL apolipoproteins: apoA-I (the principle structural protein of HDL) and apoC-I, apoC-III and apoE (three apolipoproteins which can transfer or exchange between TRL and HDL). Our results show that in terms of mass, there was approximately 2-times more apoC-III than apoE in the HDL fraction isolated by ultracentrifugation. There was approximately three-times more apoC-I than apoE, and nearly 50-times more apoA-I than apoE. Taking into account the different molecular weights of these proteins, the molar ratio in the HDL fraction was 1:7:14:60
(apoE:apoC-III:apoC-I:apoA-I). In obtaining these ratios, it is important to note that we have assumed that any apoC-I, apoC-III or apoE in the d > 1.21 g/ml fraction was HDL apolipoprotein. For apoC-I and apoC-III, this represented less than 3% of total plasma, however for apoE there was 14.6 ± 0.9% of total apoE in the bottom fraction. It is generally accepted that this represents apoE that is stripped away from lipoproteins during sequential ultracentrigation (33,34). As we have proposed previously (25) , there are at least three reasons to support the fact that apoE in the d > 1.21 g/ml fraction should be regarded as HDL apoE: 1) FPLC separation of plasma lipoproteins (which avoids the high sheer stress of UTC and therefore does not result in dissociation apoE from lipoproteins) provides an HDL apoE concentration of 2.3 ± 0.3 mg/dl for normolipidemic subjects (NL, n = 12) and 2.0 ± 0.3 for combined hyperlipidemic subjects (CHL, n = 12) (32). Combining HDL and d > 1.21 g/ml apoE gives similar concentrations for "HDL apoE" (i.e., 2.9 ± 0.3 mg/dl for NL subjects and 2.1 ± 0.3 mg/dl for CHL subjects) (25 higher in HTG subjects. ApoA-I can also be stripped from HDL by ultracentrifugation (35) , and for this reason we have taken total plasma apoA-I concentration to represent apoA-I in HDL.
Assuming that there are 2-4 molecules of apoA-I in each HDL particle, the aforementioned data suggest that less than 10% of all HDL particles in the circulation contain apoE, less than half contain apoC-I and about two-thirds contain apoC-III.
These apolipoproteins are not evenly distributed among apoA-I-containing particles since, for example, apoE is found in larger (9-18.5 nm) particles, which tend to have slow pre-beta migration on agarose gels. ApoC-III on the other hand, like apoA-II, is found in smaller (5-12 nm) α-migrating HDL (36). Some HDL particles evidently contain more than one exchangeable apolipoprotein, or alternatively more than one copy of apoC-I, apoC-III and/or apoE. In view of this particle heterogeneity, it is not surprising that HDL apos have significantly different rates of transport and significantly different residence times (Table II) . In molar terms, apoE had the lowest and apoA-I had the highest TR and the ratio between TRs was 1:2:4:12 (apoE:apoC-III:apoC-I:apoA-I). .day -1 and RT was 3.2 days, which compares to 0.9 ± 0.1 mg.kg -1
.day -1 and 3.7 ± 0.3 days, resp. in the present study. As far as apoE is concerned, a recent study by significantly correlated with RT and not with TR, while levels of HDL apoC-I, apoC-III and apoE were significantly correlated with their TRs and not their RTs (Fig. 2) . These data suggest that catabolism rather than production is the major determinant of HDL apoA-I levels, as suggested by previous studies (43) (44) (45) . In contrast, production rather than catabolism is the major determinant of plasma levels of HDL apoC-I, apoC-III and apoE. Production, as measured by rate of transport in the present study, could A final significant feature of the present study is the consistent positive correlations that were observed between HDL apoC-III and apoA-I metabolic parameters. For the sake of clarity, these statistically significant relationships (P < 0.05) are presented diagramatically in Fig. 3 . Firstly, HDL apoC-III levels were found to be positively correlated with those of HDL-C and HDL apoA-I. Secondly, HDL apoC-III transport rates were correlated with HDL-C, HDL apoC-III and HDL apoA-I. And finally, a positive relationship was found between HDL apoC-III transport rates and HDL apoA-I residence times, meaning that HDL apoC-III production was inversely correlated with HDL apoA-I catabolism. Similar relationships were not observed for HDL apoC-I or HDL apoE. Plasma levels of HDL were therefore more strongly linked to the metabolism of by guest, on October 30, 2017
www.jlr.org Downloaded from HDL apoC-III than to HDL apoC-I or HDL apoE. This is not to say that apoC-I and apoE do not have significant roles to play in HDL metabolism, but simply that the link between apoC-III metabolism and HDL was the most evident in vivo. We favor the view that this represents an effect of apoC-III on HDL catabolism and hence HDL levels, rather than an effect of HDL levels on apoC-III concentration and production. One possibility is that increased production of HDL apoC-III and/or increased flux of apoC-III into HDL results in increased levels of HDL apoC-III and subsequent inhibition of HDL catabolism. This Together, these data support the concept that apoC-III may play an important role in regulating HDL catabolism -a concept that deserves further investigation in isolated tissues and cultured cells. Significantly correlated: * P < 0.05, ** P < 0.01. 
